However, in a study on PDAC, deletion of α-SMA+CAFs promotes tumor progression by increasing the number of CD4+ FOXP3+ Treg cells in tumors [123], suggesting that this subset has an important anticancer role in PDAC. The gene discussed is CD4; the disease is neoplasm.